CNAs most commonly occurred in breast (4907/37 120, 13.2%), uterine (96/1764, 5.4%), and female neuroendocrine cancer (encompasses neuroendocrine carcinomas of the breast, cervix, ovary, uterus, vagina, and vulva; 22/362, 6.1%), with most CNAs being detected in FGFR1 (Supplementary Figure S1, available at https://doi.org/10.1016/j.esmoop.2022.100641). This evidence concerns the gene FGFR1 and neuroendocrine carcinoma.